Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era.

Autor: Osherov AB, Borovik-Raz M, Aronson D, Agmon Y, Kapeliovich M, Kerner A, Grenadier E, Hammerman H, Nikolsky E, Roguin A

Publikováno v: American Heart Journal; Jun2009 Supplement, Vol. 157 Issue 6, p1074-1080, 7p

A calcified chronic total occlusion preclinical model.

Autor: Osherov AB; Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel., Qiang B; Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Butany J; McLaughlin Centre for Molecular Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Pathology, University Health Network, Toronto, Ontario, Canada., Wright GA; Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.; Department of Medical Biophysics, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Strauss BH; Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2021 Feb 15; Vol. 97 (3), pp. 437-442. Date of Electronic Publication: 2020 Apr 03.

Distal coronary embolization following acute myocardial infarction increases early infarct size and late left ventricular wall thinning in a porcine model.

Autor: Thomas RM; Schulich Heart Centre, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room D-406, Toronto, ON, M4N 3M5, Canada. reuben.thomas@mail.utoronto.ca.; University of Toronto, Toronto, Canada. reuben.thomas@mail.utoronto.ca., Lim SY; Schulich Heart Centre, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room D-406, Toronto, ON, M4N 3M5, Canada. vnlover@hanmail.net.; University of Toronto, Toronto, Canada. vnlover@hanmail.net.; Korea University Ansan Hospital, Ansan, Korea. vnlover@hanmail.net., Qiang B; Schulich Heart Centre, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room D-406, Toronto, ON, M4N 3M5, Canada. beipingqiang@yahoo.com.; University of Toronto, Toronto, Canada. beipingqiang@yahoo.com., Osherov AB; Schulich Heart Centre, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room D-406, Toronto, ON, M4N 3M5, Canada. uziosherov@yahoo.com.; Barzilai Medical Centre, Ashkelon, Israel. uziosherov@yahoo.com., Ghugre NR; Physical Sciences Platform, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada. nghugre@gmail.com.; University of Toronto, Toronto, Canada. nghugre@gmail.com., Noyan H; Toronto General Research Institute, Toronto, Canada. h.noyanashraf@utoronto.ca.; University of Toronto, Toronto, Canada. h.noyanashraf@utoronto.ca., Qi X; Physical Sciences Platform, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada. xiuling.qi@sri.utoronto.ca., Wolff R; Schulich Heart Centre, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room D-406, Toronto, ON, M4N 3M5, Canada. wolffdr@hotmail.com.; University of Toronto, Toronto, Canada. wolffdr@hotmail.com., Ladouceur-Wodzak M; Schulich Heart Centre, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room D-406, Toronto, ON, M4N 3M5, Canada. michelle.rose21@gmail.com., Berk TA; Schulich Heart Centre, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room D-406, Toronto, ON, M4N 3M5, Canada. toviberk@gmail.com., Butany J; Department of Pathology, University Health Network, Toronto, Canada. Jagdish.Butany@uhn.ca.; University of Toronto, Toronto, Canada. Jagdish.Butany@uhn.ca., Husain M; Toronto General Research Institute, Toronto, Canada. Mansoor.Husain@uhn.ca.; University of Toronto, Toronto, Canada. Mansoor.Husain@uhn.ca., Wright GA; Schulich Heart Centre, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room D-406, Toronto, ON, M4N 3M5, Canada. gawright@sri.utoronto.ca.; Physical Sciences Platform, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada. gawright@sri.utoronto.ca.; University of Toronto, Toronto, Canada. gawright@sri.utoronto.ca., Strauss BH; Schulich Heart Centre, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room D-406, Toronto, ON, M4N 3M5, Canada. bradley.strauss@sunnybrook.ca.; University of Toronto, Toronto, Canada. bradley.strauss@sunnybrook.ca.

Publikováno v: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance [J Cardiovasc Magn Reson] 2015 Dec 01; Vol. 17, pp. 106. Date of Electronic Publication: 2015 Dec 01.

Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.

Autor: Gotha L; Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;, Lim SY; Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Korea University Ansan Hospital, Ansan, Korea., Osherov AB; Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;, Wolff R; Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;, Qiang B; Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;, Erlich I; Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;, Nili N; Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;, Pillarisetti S; Dr. Reddy's Laboratories, Norcross, Georgia;, Chang YT; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; and., Tran PK; Department of Pediatric Cardiac Surgery, Skane University Hospital, Lund, Sweden;, Tryggvason K; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; and., Hedin U; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; and., Tran-Lundmark K; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; and., Advani SL; Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada;, Gilbert RE; Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada;, Strauss BH; Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; bradley.strauss@sunnybrook.ca.

Publikováno v: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2014 Aug 01; Vol. 307 (3), pp. H337-45. Date of Electronic Publication: 2014 May 23.

Therapeutic angiogenesis with VEGF164 for facilitation of guidewire crossing in experimental arterial chronic total occlusions.

Autor: Teitelbaum AA; Schulich Heart Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada., Qi X, Osherov AB, Fraser AR, Ladouceur-Wodzak M, Munce N, Qiang B, Weisbrod M, Bierstone D, Erlich I, Sparkes JD, Wright GA, Strauss BH

Publikováno v: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2013 Jan 22; Vol. 8 (9), pp. 1081-9.